Formula Growth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Formula Growth’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,800	Closed	-$1.11M	–	150
2020 Q3	$1.11M	Hold	7,800	–	–	0.21%	111
2020 Q2	$861K	Hold	7,800	–	–	0.15%	120
2020 Q1	$778K	Hold	7,800	–	–	0.15%	107
2019 Q4	$1.16M	Hold	7,800	–	–	0.15%	113
2019 Q3	$999K	Hold	7,800	–	–	0.15%	120
2019 Q2	$1.11M	Hold	7,800	–	–	0.16%	117
2019 Q1	$1.11M	Hold	7,800	–	–	0.16%	112
2018 Q4	$967K	Hold	7,800	–	–	0.16%	107
2018 Q3	$1.31M	Hold	7,800	–	–	0.15%	115
2018 Q2	$1.34M	Hold	7,800	–	–	0.15%	116
2018 Q1	$1.18M	Hold	7,800	–	–	0.14%	124
2017 Q4	$1.05M	Hold	7,800	–	–	0.14%	114
2017 Q3	$1.14M	Hold	7,800	–	–	0.18%	113
2017 Q2	$1.21M	Hold	7,800	–	–	0.21%	106
2017 Q1	$1.13M	Hold	7,800	–	–	0.24%	112
2016 Q4	$850K	Hold	7,800	–	–	0.2%	119
2016 Q3	$948K	Sell	7,800 -3,700	-32%	-$499K	0.21%	123
2016 Q2	$1.63M	Sell	11,500 -6,000	-34%	-$885K	0.4%	84
2016 Q1	$2.29M	Hold	17,500	–	–	0.55%	64
2015 Q4	$2.46M	Buy	+17,500	New	+$2.43M	0.57%	56

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Formula Growth's JAZZ Position: Q4 2020 in Review

Formula Growth sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2020, closing a stake of 7,800 shares — an estimated $1.11M sold.

Formula Growth first reported a position in JAZZ in Q4 2015 and held it in 20 quarters. The position peaked at $2.46M in Q4 2015. 437 funds tracked by Wall St. Rank hold JAZZ as of Q4 2020.

Formula Growth reported no remaining Jazz Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Formula Growth sold 7,800 Jazz Pharmaceuticals shares in Q4 2020, an estimated $1.11M.
Formula Growth first reported a position in Jazz Pharmaceuticals in Q4 2015 and held it in 20 quarters.
Formula Growth's Jazz Pharmaceuticals position peaked at $2.46M in Q4 2015.
437 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2020.

Based on Formula Growth's 13F filing for Q4 2020, filed 12 Feb 2021.